Japan Drug Repurposing Market was valued at USD 3.0 Billion in 2022 and is projected to reach USD 6.5 Billion by 2030, growing at a CAGR of 9.5% from 2024 to 2030.
The Japan drug repurposing market has witnessed significant growth due to the increasing focus on finding new uses for existing drugs. Drug repurposing, also known as drug repositioning, involves identifying new therapeutic indications for existing medications, which can lead to faster development timelines and reduced costs. In Japan, this approach has gained momentum across various applications, including oncology, neurology, and cardiology. The oncology segment is particularly notable, as many drugs originally developed for other purposes have shown efficacy in treating various cancers. This trend is driven by the high prevalence of cancer in Japan and the need for more effective treatment options.
Neurology is another critical application area for drug repurposing in Japan. Many neurological disorders, such as Alzheimer’s disease and Parkinson’s disease, present significant challenges for current treatments. Researchers are exploring existing drugs that might be effective in managing or slowing the progression of these conditions. The potential for drug repurposing to offer new solutions for these complex diseases is promising. The emphasis on neurology reflects the growing recognition of the need for innovative approaches to tackle neurodegenerative disorders that are prevalent in the aging Japanese population.
Get an In-Depth Research Analysis of the Japan Drug Repurposing Market Size And Forecast [2025-2032]
Pfizer
Roche
Novartis AG
Abbott Healthcare
Johnson & Johnson
Sandoz
Mylan Inc.
Teva Pharmaceuticals
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Japan Drug Repurposing Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Japan Drug Repurposing Market
Cardiovascular Disorders
Central Nervous Disorders
Oncology
Others
Based on Types the Market is categorized into Below types that held the largest Drug Repurposing market share In 2023.
Intravenous
Oral
Japan (United States, Japan and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Drug Repurposing Market Research Analysis
1. Introduction of the Japan Drug Repurposing Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Japan Drug Repurposing Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Japan Drug Repurposing Market, By Type
6. Japan Drug Repurposing Market, By Application
7. Japan Drug Repurposing Market, By Geography
Japan
Europe
Asia Pacific
Rest of the World
8. Japan Drug Repurposing Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Japan Research and Consulting firm servicing over 5000+ Japan clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/